Publikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (27)

2024

  1. Methodology for the induction of myocardial infarction and cardiac function evaluation

    Methods in Cell Biology (Academic Press Inc.), pp. 151-164

2022

  1. Importance of cardiac imaging assessment of epicardial adipose tissue after a first episode of myocardial infarction

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Mitochondrial Oxidative Stress Promotes Cardiac Remodeling in Myocardial Infarction through the Activation of Endoplasmic Reticulum Stress

    Antioxidants, Vol. 11, Núm. 7

2021

  1. Role of endoplasmic reticulum stress in renal damage after myocardial infarction

    Clinical Science, Vol. 135, Núm. 1, pp. 143-159

2020

  1. Identification of a plasma microrna signature as biomarker of subaneurysmal aortic dilation in patients with high cardiovascular risk

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14

  2. The Crosstalk between Cardiac Lipotoxicity and Mitochondrial Oxidative Stress in the Cardiac Alterations in Diet-Induced Obesity in Rats

    Cells, Vol. 9, Núm. 2

2019

  1. The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction

    Scientific Reports, Vol. 9, Núm. 1

  2. The role of mitochondrial oxidative stress in the metabolic alterations in diet-induced obesity in rats

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 11, pp. 12060-12072

2017

  1. The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats

    Journal of Molecular and Cellular Cardiology, Vol. 92, pp. 96-104

2015

  1. Galectin-3 participates in cardiovascular remodeling associated with obesity

    Hypertension, Vol. 66, Núm. 5, pp. 961-969

  2. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 6, pp. 543-551

2014

  1. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: Potential role in obesity

    Journal of Hypertension, Vol. 32, Núm. 5, pp. 1104-1114

2012

  1. Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: A novel anti-atherosclerotic mechanism

    Pharmacological Research, Vol. 66, Núm. 6, pp. 536-543

  2. The impact of bariatric surgery on renal and cardiac functions in morbidly obese patients

    Nephrology Dialysis Transplantation, Vol. 27, Núm. SUPPL.4

2010

  1. A proteomic approach to determine changes in proteins involved in the myocardial metabolism in left ventricles of spontaneously hypertensive rats

    Cellular Physiology and Biochemistry, Vol. 25, Núm. 2-3, pp. 347-358

2009

  1. The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance

    Journal of Hypertension, Vol. 27, Núm. SUPPL. 6

2007

  1. Efecto de la atorvastatina sobre la expresión vascular de los PPAR en conejos dislipémicos

    Clinica e Investigacion en Arteriosclerosis, Vol. 19, Núm. 4, pp. 166-173

  2. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 25, Núm. 3, pp. 629-638

2006

  1. Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 7, Núm. 4, pp. 192-200